US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ADARx Pharmaceuticals

17.33

-1.2500-6.73%

Volume:705.70K

Turnover:12.65M

Market Cap:1.77B

PE:-2.24

High:18.70

Open:18.33

Low:17.20

Close:18.58

52wk High:23.21

52wk Low:17.20

Shares:102.20M

Float Shares:102.20M

Volume Ratio:0.76

T/O Rate:0.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.7403

EPS(LYR):-6.4321

ROE:-38.89%

ROA:-14.90%

PB:-7.05

PE(LYR):-2.69

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772

Sector Update: Healthcare

MT Newswires Live

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ADRX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","market":"US","secType":"STK","nameCN":"ADARx Pharmaceuticals","latestPrice":17.33,"timestamp":1791403200000,"preClose":18.58,"halted":0,"volume":705703,"delay":0,"changeRate":-0.06727664155005383,"floatShares":102200905,"shares":102200905,"eps":-7.740306,"marketStatus":"Pre-Mkt","change":-1.25,"latestTime":"10-08 05:08:13 EDT","open":18.33,"high":18.7,"low":17.2,"amount":12653745.959288001,"amplitude":0.080732,"askPrice":18.6,"askSize":200,"bidPrice":6.97,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.740306,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1790308800000,"exchange":"NASDAQ","adjPreClose":17.33,"postHourTrading":{"tag":"盘后","latestPrice":17.22,"preClose":17.33,"latestTime":"19:30 EDT","volume":2655,"amount":45921.067,"timestamp":1791415801615,"change":-0.11,"changeRate":-0.006347,"amplitude":0.013272},"volumeRatio":0.7609446929838221},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","floatShares":102200905,"roa":"-14.90%","roe":"-38.89%","lyrEps":-6.432121,"volumeRatio":0.7609446929838221,"shares":102200905,"dividePrice":0,"high":18.7,"amplitude":0.080732,"preClose":18.58,"low":17.2,"week52Low":17.2,"pbRate":"-7.05","psRate":"289.07","week52High":23.21,"institutionHeld":0,"latestPrice":17.33,"committee":-0.333333,"eps":-7.740306,"divideRate":0,"volume":705703,"delay":0,"ttmEps":-7.740306,"open":18.33,"prevYearClose":17,"prevWeekClose":18.25,"prevMonthClose":19.94,"prevQuarterClose":19.94,"fiveDayClose":19.94,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADRX","date":"2026-10-06","current":-2.23893,"percent":0.666667,"low":-25.428632,"twenty":-25.048304,"median":-24.41833,"eighty":-23.634138,"high":-23.273447,"avg":-24.4118,"sd":0.7499,"marketCap":2134683316},"quantilePoints":[{"date":"2026-10-02","current":-24.918529,"twenty":-25.150325,"median":-24.918529,"eighty":-24.228516,"marketCap":2189591181},{"date":"2026-10-06","current":-24.293653,"twenty":-25.048304,"median":-24.41833,"eighty":-23.634138,"marketCap":2134683316}],"updateTime":1791408752729},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADRX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672764099","title":"ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764099","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764099?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:15","pubTimestamp":1790885700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  01, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx) (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373408/0/en/adarx-pharmaceuticals-announces-the-closing-of-full-exercise-of-underwriters-option-to-purchase-additional-shares-granted-in-its-initial-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU2111349929.HKD","LU2357305700.SGD","LU0267386448.USD","LU1244550494.USD","LU0314104364.USD","LU1244550221.USD","LU1791710582.SGD","LU0528227936.USD","LU1548497426.USD","LU0882574139.USD","LU1988902786.USD","LU0557290698.USD","LU0795875086.SGD","LU1363072403.SGD","LU2023251221.USD","BK4585","LU0912757837.SGD","LU1720051017.SGD","BK4588","LU0106831901.USD","IPOS","LU2089284900.SGD","LU0098860793.USD","LU2487616109.SGD","IE00B775SV38.USD","LU0390134368.USD","LU1791710400.SGD","LU0210528500.USD","LU2133065610.SGD","LU2028103732.USD","LU0053666078.USD","LU0158827948.USD","KBWB","LU0225283273.USD","LU1244550577.SGD","IE00B3S45H60.SGD","LU0158827781.USD","LU0971096721.USD","BK4516","BK4127","LU2347655156.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1989772923.USD","LU1989772840.SGD","IAI","ADRX","LU0795875169.SGD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672975314","title":"Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772","url":"https://stock-news.laohu8.com/highlight/detail?id=2672975314","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672975314?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:57","pubTimestamp":1790845022,"startTime":"0","endTime":"0","summary":"Adarx director Erez Chimovits acquires 61,516 shares worth $1,045,772Adarx Pharmaceuticals director Erez Chimovits reported an increase in indirect beneficial ownership to 9,292,025 common shares.Fili","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLb2T6FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adarx Director Erez Chimovits Acquires 61,516 Shares Worth $1,045,772","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670842145","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670842145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670842145?lang=en_us&edition=fundamental","pubTime":"2026-09-26 03:28","pubTimestamp":1790364536,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index gaining 0.4% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  increased 0.3%.In corporate news, ADARx Pharmaceuticals  shares jumped 18% in their Nasdaq debut after an initial public offering that raised $446.3 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3QW5Z07.USD","BK4135","BK4550","IE00BGHQF748.EUR","XBI","ADRX","BK4588","LABU","FDN","LU1894683264.USD","XLV","IE0034235188.USD","STT","IBB","LU0029874061.USD","LU0061475181.USD","IE00B64PRP62.GBP","LU1894683348.USD","BK4585","BK4581","HCSG","BK4137","LU0128526141.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442662","title":"ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442662","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442662?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353284,"startTime":"0","endTime":"0","summary":"UPDATE 2-ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPOSept 25 (Reuters)-Shares of ADARx PharmaceuticalsADRX.Orose 30% above their initial public offering price on Friday after th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H0ML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","JDOC","LU0965509283.SGD","LU1983299246.USD","ADRX","GLAM","LU0158827948.USD","LU0912757837.SGD","LU0098860793.USD","IE00BDGV0183.EUR","LU1061106388.HKD","LU0058720904.USD","LU0942090050.USD","IXJ","AGNG","IE0009355771.USD","TRUH","LU0823416689.USD","LU2023251221.USD","LU2237443465.HKD","ABBV","ETRA","IYH","LU1670627923.USD","PJP","RXL","VHT","LU1839511570.USD","IE00B42XCP33.USD","IE00B19Z3581.USD","LU0868494617.USD","IE00BSNM7G36.USD","IE00BGHQF631.EUR","PPH","LU2129689605.HKD","LU1003077747.HKD","IE00B4R5TH58.HKD","BK4585","LU1037948897.HKD","FTXH","XLV","LU2237443382.USD","LU1989771016.USD","LU1548497426.USD","LU0511384066.AUD","LU1929549753.HKD","LU0545039389.USD","LU0320765646.SGD","IE0000B7K699.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ADRX\",params:#limit:6,delay:false,,,undefined,":[]}}